X PARSOLEX PARTNER SOLUTIONS EXCELLENCE - Trademark Details
Status: 700 - Registered
Serial Number
88570483
Registration Number
6356727
Word Mark
X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
Status
700 - Registered
Status Date
2021-05-18
Filing Date
2019-08-07
Registration Number
6356727
Registration Date
2021-05-18
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
021101, 100901, 241504, 241510 - Hearts. Medicines and nonmedical products in tablet, capsule or powder form; suppositories. Arrowheads. More than one arrow.
Published for Opposition Date
2020-07-28
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
BULLOFF, TOBY ELLEN
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"SOLUTIONS"
Description of Mark
The mark consists of a stylized design comprised of two diagonal intersecting pill capsules forming a heart shaped arrow design on the left side and creating an "x" shape; the design element appears to the left of the wording "Parsolex"; centered underneath the design and "Parsolex" wording appears the wording "PARTNER SOLUTIONS EXCELLENCE".
Goods and Services
Consulting services in the fields of pharmaceutical, medical and healthcare research and development; technical services, namely, research and development in the pharmaceutical and biotechnology fields; consulting services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances and pharmaceutical technology transfer being advice and information about pharmaceutical research and design; technical services, namely, providing advice, information and instructions for pharmaceutical formulation design and design of processes to transform inorganic and organic substances, pharmaceutical technology transfer being advice and information about pharmaceutical research and design; pharmaceutical product chemical and physical evaluation services, namely, test method development, test method validation, use of test methods for in-process control, quality control, and product release, and technology transfer being advice and information about pharmaceutical test methods; analytical chemistry services, namely, developing and validating test methods for drug product release; technology transfer being advice and information about the drug product testing process and test methods; providing services to others in the fields of analytical, chemistry and manufacturing controls for the production and regulatory approval of pharmaceuticals, namely, providing scientific information relating to the analysis and management of the pharmaceutical manufacturing process for the production, packaging, and regulatory approval of pharmaceuticals; consulting services in the fields of chemistry, biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; consulting and research and development services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; technical consulting in the fields of pharmaceutical studies, research and development; technical consulting in the field of pharmaceutical development and engineering; technical consulting in the field of analytical chemistry services; consultancy pertaining to pharmacology; technology consultation in the fields of research and development of pharmaceuticals, medicines and healthcare products; scientific research consulting in the fields of pharmaceuticals, medicines and healthcare products; product development consulting in the fields of pharmaceuticals, medicines and healthcare products; scientific research services relating to pharmaceuticals, medicines and healthcare products; product development consultation; product development services; formulation and process design services for drug products for others; outsource service provider for manufacturing and packaging of pharmaceuticals; formulation and process design services for drug products for others; design of packaging for pharmaceuticals of others; pharmaceutical product packaging design services for others; formulation and process design services for drug products of others; provision of information, advice and consultancy in relation to pharmaceutical packaging design; technical consulting in the field of pharmaceutical research and development; custom pharmaceutical service provider, namely, pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; consulting in the areas of pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; development of custom pharmaceuticals for others; design of packaging for pharmaceuticals for others; formulation and process design services for drug products for others
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-08-24
Primary Code
042
First Use Anywhere Date
2019-10-28
First Use In Commerce Date
2019-10-28
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jill J. Chalmers
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-08-10 | NEW APPLICATION ENTERED IN TRAM |
2019-08-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-08-27 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2019-10-16 | ASSIGNED TO EXAMINER |
2019-10-31 | PRIORITY ACTION WRITTEN |
2019-10-31 | PRIORITY ACTION E-MAILED |
2019-10-31 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
2020-04-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-04-15 | ASSIGNED TO LIE |
2020-04-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-04-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-04-22 | EXAMINERS AMENDMENT -WRITTEN |
2020-04-22 | EXAMINERS AMENDMENT E-MAILED |
2020-04-22 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-04-22 | EXAMINER'S AMENDMENT ENTERED |
2020-04-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-05-06 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-05-26 | PUBLISHED FOR OPPOSITION |
2020-05-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-06-15 | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST |
2020-06-16 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2020-06-16 | EXAMINERS AMENDMENT -WRITTEN |
2020-06-16 | EXAMINERS AMENDMENT E-MAILED |
2020-06-16 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-06-16 | EXAMINER'S AMENDMENT ENTERED |
2020-06-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-06-24 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2020-07-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-07-28 | PUBLISHED FOR OPPOSITION |
2020-07-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-09-22 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-03-17 | TEAS STATEMENT OF USE RECEIVED |
2021-04-01 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-03-17 | USE AMENDMENT FILED |
2021-04-02 | STATEMENT OF USE PROCESSING COMPLETE |
2021-04-15 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2021-04-16 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2021-05-18 | REGISTERED-PRINCIPAL REGISTER |